Coventry University Featured PhD Programmes
University of Edinburgh Featured PhD Programmes
University of Glasgow Featured PhD Programmes
Catalysis Hub Featured PhD Programmes
University of Reading Featured PhD Programmes
"brain" AND "tumour"×
10 miles

brain tumour PhD Projects, Programs & Scholarships

We have 10 brain tumour PhD Projects, Programs & Scholarships

  • "brain" AND "tumour" ×
  • clear all
Order by 
Showing 1 to 10 of 10
  Targeted reversal of epigenetic silencing at specific tumour suppressor genes in lymphoma
  Dr R Jenner, Dr J Fitzgibbon
Application Deadline: 18 March 2019
This 4-year PhD studentship is offered by the Cancer Research UK City of London Centre. This project seeks to develop a novel biological therapy to precisely modulate the epigenetic state of specific tumour suppressor genes in lymphoma.
  Developing novel treatments for rare childhood brain tumours
  Prof R Gilbertson
Application Deadline: 12 April 2019
Despite decades of research, the treatment of brain tumours has remained largely unchanged. These cancers are treated with an aggressive combination of neurosurgery, radiation and chemotherapy that fails to cure but damages the surrounding normal brain, leaving survivors with devastating side effects.
  Breaking the HGF-cMET axis in medulloblastoma: development of small non-sugar glycosaminoglycan (GAG) mimics as anti-metastatic drugs.
  Dr G Di Leva
Applications accepted all year round
Medulloblastoma (MB) is the most common malignant paediatric brain tumour accounting for about 20% of all childhood brain cancers.
  Development of novel inhibitors for the treatment of Glioblastomas
  Dr S Ahmed, Dr S Darby
Applications accepted all year round
Glioblastoma (GBM) is the most common form of brain tumour in adults and is incurable. Despite optimal treatment consisting of surgery, chemotherapy and radiotherapy, median survival is 15 month.
  Deep learning for early detection of cancer recurrence in patients with glioblastoma through imaging
  Dr A Gooya
Application Deadline: 1 August 2019
rain tumours are cancer of unmet need and are the most common cause of cancer death in under the 40s. Glioblastoma is the most common primary adult brain tumour and carries one of the worst prognoses amongst human cancers, with a median survival time of about 15 months.
  How does amino acid metabolism affect tumour growth?
  Dr L. Cheng
Applications accepted all year round
The effect of diet on tumour growth is hotly debated but poorly characterized. Due to the heterogeneous nature of the tumours, dietary studies in patients with varied genetic background often led to inconclusive outcome.
  MRC Precision Medicine DTP: Quantitative proteomic analysis of dysregulated adhesion protein localisation in patient-derived cancer cells
  Research Group: Edinburgh Cancer Research Centre
  Dr A Byron, Prof M Frame, Prof R Zubarev, Dr A Sims
Application Deadline: 8 April 2019
Summary. This project seeks to use proteomic data and computational approaches to identify signatures of cell adhesion proteins that are mislocalised in cells from brain cancer patients.
  CRUK Clinical Research Training Fellowship: developing novel T-cell immunotherapy for paediatric high grade glioma
  Dr K Straathof, Prof D Hargrave, Prof J Anderson
Application Deadline: 27 March 2019
Overall aim of the PhD project is to develop novel T-cell immunotherapy for paediatric high grade glioma. Brain tumours are the major cause of cancer-related death in children, overtaking the other paediatric cancers including leukaemias and other solid tumours.
  Prodrugs Activated by Tumour Microenvironment
  Research Group: Institute of Cancer Therapeutics
  Dr R Wheelhouse, Prof P Loadman, Prof R M Phillips
Applications accepted all year round
The anticancer drug temozolomide (TMZ), has been in the clinic for treating brain tumours for nearly 30 years. Despite its “Blockbuster” status, no other compounds of this class have reached clinical trial.
  Nano4CaRE: (Nanoparticles for Cancer Radiotherapy Enhancement)
  Dr N Bricklebank, Dr N Cross, Dr R Leyland
Application Deadline: 12 April 2019
TPP-functionalisation will promote the uptake of nanoparticles by cancer cells. Radiosensitisation will be improved by varying the size and ligand density of the TPP-nanoparticles.
Show 10 15 30 per page
  • 1


FindAPhD. Copyright 2005-2019
All rights reserved.